Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Johnson & Johnson Stock Rose Today

TheMotleyFool

0 0

Why Johnson & Johnson Stock Rose TodayPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Shares of Johnson & Johnson (NYSE: JNJ) rallied 3% on Tuesday, following the release of the healthcare behemoth's first-quarter financial results.

J&J's revenue grew by 5% to $23.4 billion. The gains were driven by a 6.3% rise in the company's pharmaceutical sales and a 5.9% increase in medical device sales. A 1.5% decline in consumer health revenue, which was hurt by global supply chain disruptions, partly offset these gains.

"Our first-quarter results demonstrate strong performance across the enterprise, despite macro-economic headwinds," CEO Joaquin Duato said in a press release.

Source Fool.com

Like: 0

JNJ

Teilen